首页> 外文期刊>AIDS >Endothelial activation biomarkers increase after HIV-1 acquisition: Plasma vascular cell adhesion molecule-1 predicts disease progression
【24h】

Endothelial activation biomarkers increase after HIV-1 acquisition: Plasma vascular cell adhesion molecule-1 predicts disease progression

机译:HIV-1感染后内皮细胞活化生物标志物增加:血浆血管细胞粘附分子-1预测疾病进展

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: We aimed to determine whether endothelial activation biomarkers increase after HIV-1 acquisition, and whether biomarker levels measured in chronic infection would predict disease progression and death in HIV-1 seroconverters. DESIGN: HIV-1-seronegative Kenyan women were monitored monthly for seroconversion, and followed prospectively after HIV-1 acquisition. METHODS: Plasma levels of angiopoietin-1 and angiopoietin-2 (ANG-1, ANG-2) and soluble vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin were tested in stored samples from pre-infection, acute infection, and two chronic infection time points. We used nonparametric tests to compare biomarkers before and after HIV-1 acquisition, and Cox proportional-hazards regression to analyze associations with disease progression (CD4 <200a??cells/μl, stage IV disease, or antiretroviral therapy initiation) or death. RESULTS: Soluble ICAM-1 and VCAM-1 were elevated relative to baseline in all postinfection periods assessed (Pa??
机译:目的:我们旨在确定HIV-1感染后内皮细胞活化生物标志物是否增加,以及在慢性感染中检测到的生物标志物水平是否可以预测HIV-1血清转换器的疾病进展和死亡。设计:每月对HIV-1血清阴性的肯尼亚妇女进行血清转化监测,并在HIV-1感染后进行前瞻性随访。方法:血浆血浆血管生成素-1和血管生成素-2(ANG-1,ANG-2),可溶性血管细胞粘附分子-1(VCAM-1),细胞间粘附分子-1(ICAM-1)和E-选择素从感染前,急性感染和两个慢性感染时间点对储存的样本进行了测试。我们使用非参数测试来比较HIV-1采集前后的生物标记,并使用Cox比例风险回归分析与疾病进展(CD4 <200a?细胞/μl,IV期疾病或开始抗逆转录病毒治疗)或死亡的相关性。结果:在所有评估的感染后时期中,可溶性ICAM-1和VCAM-1相对于基线均升高(Pa ?? ?? 0.0001)。在急性感染中可溶性E-选择素和ANG-2:ANG-1比值增加(Pa ?? = a ?? 0.0001),而在慢性感染中ANG-1降低(Pa ?? = a ?? 0.0004)。在228位参与者中,有超过1028人年的随访,其中115位经历了疾病的恶化或死亡。在调整了设定血浆血浆病毒载量,感染年龄,和可溶性ICAM-1水平。结论:HIV-1的获得与内皮细胞的活化有关,并且感染后可溶性ICAM-1和VCAM-1的持续升高。可溶性VCAM-1可能是信息丰富的生物标志物,可预测HIV-1疾病进展,发病率和死亡率的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号